The Increasing Prevalence of Gout in the World Is Driving Gout Disease Treatment Market Growth

Gout Disease Treatment Market
Gout Disease Treatment Market


Gout Disease Treatment Market, by Drug Class (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Colchicine, Urate-lowering Agents, and Monoclonal Antibody), by Route of Administration (Oral and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027.

Market Overview:

Gout is a type of arthritis that occurs when uric acid builds up in the blood and forms crystals in the joints. This can cause sudden and severe pain, swelling, and redness in the affected joint. Gout typically affects the big toe, but can also occur in other joints such as the ankle, knee, wrist, and elbow. Gout is a chronic condition that can lead to joint damage and other complications if left untreated. It is often treated with medication and lifestyle changes, such as a low-purine diet and weight loss. Gout is more common in men than in women and is often associated with other health conditions such as high blood pressure, diabetes, and kidney disease.

Competitive Landscape:

Major players operating in the global gout disease treatment market include Zyla Life Sciences (Pty) Ltd., CymaBay Therapeutics, Inc., Ironwood Pharmaceuticals, Inc., Hikma Pharmaceuticals Plc, Horizon Therapeutics Plc., JW Pharmaceutical Corporation, Simcere Pharmaceutical, Teijin Pharma Limited, Novartis International AG, Takeda Pharmaceutical Company Limited, and AstraZeneca Plc.

Key Market Drivers:

The increasing prevalence of gout disease in the world is expected to augment the growth of the global gout disease treatment market. For instance, according to the National Institutes of Health (NIH), globally around 7.44 million individuals are living with gout disease. For instance, according to the National Institutes of Health (NIH), globally around 7.44 million individuals are living with gout disease.

The growing awareness about gout and its symptoms and the development of new drugs and treatment options in the world are estimated to enhance the growth of the global gout disease treatment market.

Covid-19 Impact Analysis:

The COVID-19 pandemic has had a mixed impact on the gout disease treatment market. While the pandemic has led to a decline in hospital visits, which has affected the diagnosis and treatment of gout patients, the increasing adoption of telemedicine and online consultations has helped maintain the continuity of care for patients. Additionally, the demand for gout treatment has remained stable, with patients continuing to require treatment despite the pandemic. For instance, in March 2022, Atom Bioscience published the positive results of the clinical trial related to ABP-671, which will be used to treat chronic gout disease.

Key Takeaways:

·         North America is expected to dominate the growth of the global gout disease treatment market, owing to the high prevalence of gout and the presence of major market players in the region. For instance, according to JAMA Network, around 9.2 million individuals in the United States are suffering from gout disease.

·         Asia-Pacific is estimated to witness significant growth in the global gout disease treatment market, owing to the increasing prevalence of gout and rising healthcare expenditure in the region. For instance, in March 2022, Stride Pharma got the approval of the United States Food and Drug Administration, for its Colchicine tablets, which will be used to prevent and treat gout disease.

Comments

Post a Comment

Popular posts from this blog

Rising Cancer Cases to boost the Molecular Cytogenetics Market Growth

Image
Molecular Cytogenetics Market Molecular Cytogenetics Market by Products (Kits & Reagents, Instruments, and Software & Services), Technique (Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Karyotyping, Other Techniques), Application (Cancer, Genetic Disorders, Other Applications), And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030 The global Molecular Cytogenetics Market is estimated to be valued at US$ 4,211.4 million in 2023, and is expected to exhibit a CAGR of 24.5 % over the forecast period, as highlighted in a new report published by Coherent Market Insights. Market Overview: Clinical cytogenetics is the examination of the relation between chromosomal alterations and genetic disorders in human beings. Molecular cytogenetics is an examination of genetic diseases utilizing new techniques and methods that link cytogenetic and molecular techn
Read more

Bispecific Antibodies Are Used As Therapeutic Drugs While Treating Viral Infections, Oncology, And Auto-Immune Diseases

Image
  Bispecific Antibodies Bispecific antibodies are produced through cell fusion or recombinant DNA technologies. Bispecific antibodies are much more specific than monoclonal antibodies. Their applications in tumor immunotherapy are nearly limitless. As of today, seven bispecific antibodies have been approved by the FDA and EMA and over one hundred are in preclinical testing. Bispecific antibodies were initially developed using the quadroma technology. They contain two distinct antigen-binding arms, which enable them to bind to the target antigen while also activating an effector cell, which kills tumor cells. The primary antigen on the surface of the effector cell is called CD3, which is a popular target of immune cells. According to Coherent Market insights the Bispecific Antibodies Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. Many of these multi specific antibody formats have been developed over the past 30 years. These categories of a
Read more

Organic Milk Has Much Higher Concentration Of Iron, Vitamin E, And Polyunsaturated Fatty Acids Omega-3 And Omega-6 As Compared To Regular Milk

Image
  Organic Milk Organic Milk is milk made from livestock raised using organic farming practices. The use of the term "organic" is regulated by food authorities in most jurisdictions. Organic cows are not allowed to be given hormones, which stimulate milk production. Organic feed also must be grown without the use of synthetic pesticides. Organic cows must get a certain percentage of their diet from grazing, although most organic dairies supplement the grass with grain. However, organic grazing cows produce less milk than cows that eat a grain-based diet. Buying organic milk may be a better investment for your health. According to Coherent Market Insights the Organic Milk Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. The standards for organic milk are stringent. To meet the organic standard, a dairy farm cannot use any form of animal growth hormones or antibiotics. Organic cows must spend at least 30% of their lives on pasture. C
Read more